We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radioactive Carbon Incorporated in Urea for H. Pylori Test

By LabMedica International staff writers
Posted on 26 Nov 2008
The noninvasive test method used clinically for the diagnosis of Helicobacter pylori infection and post-eradication follow-up is the urea breath test (UBT). More...
A probe for the bacteria has been developed by incorporating a radioactive isotope of carbon into the urea used for the test.

H. pylori produce an enzyme, urease, which catalyzes the hydrolysis of the urea molecule into ammonium and carbon dioxide. The urea contains one carbon atom that is replaced by the radioactive carbon isotope. The probe, developed by Stat Diagnostics Services (Mumbai, India), is called the Heliprobe instrument.

A Helicap (hard urea 14C) is ingested with 50 ml of water. When H. pylori are present in the stomach, urease metabolizes the C-urea releasing carbon dioxide containing the C-labeled atoms. The carbon dioxide passes through the mucosa into the blood stream and it is transported to the lungs where it is exhaled. The amount of CO2 produced in the stomach can be measured with the Heliprobe instrument.

If the patient is not infected, no metabolisation of urea will occur and therefore no CO2 is detected--the unmetabolised C urea will be excreted in the urine. If the Heliprobe system detects CO2, this is diagnostic evidence of an ongoing infection with H. pylori.

Related Links:
Stat Diagnostics Services



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.